Patkar, N., Kakirde, C., Shaikh, A. F., Salve, R., Bhanshe, P., Chatterjee, G., . . . Gujral, S. (2021). Clinical impact of panel-based error-corrected next generation sequencing versus flow cytometry to detect measurable residual disease (MRD) in acute myeloid leukemia (AML). Leukemia.
Citación estilo ChicagoPatkar, Nikhil, et al. "Clinical Impact of Panel-based Error-corrected Next Generation Sequencing Versus Flow Cytometry to Detect Measurable Residual Disease (MRD) in Acute Myeloid Leukemia (AML)." Leukemia 2021.
Cita MLAPatkar, Nikhil, et al. "Clinical Impact of Panel-based Error-corrected Next Generation Sequencing Versus Flow Cytometry to Detect Measurable Residual Disease (MRD) in Acute Myeloid Leukemia (AML)." Leukemia 2021.